Impact of Quality Assurance on Your Regulatory and Clinical Strategy

In this studio conversation, Joseph Sapiente, MDIC’s Senior Vice President of Science and Technology, discusses the critical role of quality assurance in shaping regulatory and clinical strategies. Joined by Al Crouse, Head of Quality at CVRx, and George Serafin, CEO of NanoDX, the panel explores essential topics including product classification, preclinical and clinical strategies, and the growing role of simulation and modeling in development. They also highlight the importance of risk management and enterprise-wide approaches to ensuring data integrity, biocompatibility, and cybersecurity in clinical trials. Learn how QA strategies can align with regulatory requirements and drive success from development to market. A must-watch for MedTech professionals striving to integrate quality into every stage of the product lifecycle.